Toilet Stock. More money will bleed out on Monday. That’s all it ever does. It is not a Covid stock. For myself, huge mistake.
Please someone explain the sudden change in volume, in layman’s terms, Tysm
Please can someone explain the volume? I’m a newer trader. In layman’s terms. Tysm
Meant to say write. I misspelled because I’m so upset.
Write. Sorry. I can spell. Lol.
I am not a big time investor. I’m stuck in this pos stock. I’m now convinced more then ever this Company is Shady. I had 30 shares limit buy at 3.95. I saw it drop to pick it up then right back up. I don’t know much but I’m convinced this is rigged. It’s doing it again as I right this. Dipping down sudden then back up.
It’s going nowhere.
Any year now. Maybe 2022 will be the year
If Gladisvir was even possibly going to be a contender in Covid wouldn’t there be some shred of news out on that lately? I hope the positive hopes are correct but it feels like grasping at straws at this point. This stock needs to S—- or get off the pot. There’s just crickets on BCRX.
It just keeps getting better and better. Nightmare stock
Shady Shady something is not right here. Controlled stock. Live and learn. First dilution then you notice the pattern.
Manipulated stock. Want out. Waste of time.
Let’s be honest this stock is broken. NG
Same volume same price range day in and day out. Like watching paint dry
Why doesn’t this stock ever move? If I was even ,I’d get out and buy back later. It just shows no signs of life.
It’s just stuck! Zzzzz
Re Dexamethasone is all you need, that news states it’s for severe cases and patients are already vented. The key would be meds that treat you before you get to that point.
@Vafa sorry my words connected. Can’t find edit here.
@Vafabbut when will that news hit be? The last news didn’t do anything imo.
Company still selling shares at 4.50 target? They are still raising cash? How many shares do they have left to sell?
|2021-08-06||RBC Capital||Upgrade||Sector Perform|
|2021-08-06||JMP Securities||Upgrade||Market Outperform|
|2021-08-06||HC Wainwright & Co.||Upgrade||Buy|
|2021-09-14||ABERCROMBIE GEORGE B||Director||0.00||Sale|
|2021-08-30||ASELAGE STEPHEN J||Director||32.44K||Stock Award(Grant)|
|2021-05-11||BARNES ALANE P||Officer||146.13K||Conversion of Exercise of derivative security|
|2021-08-30||HEGGIE THERESA||Director||14.79K||Stock Award(Grant)|
|2021-06-09||HUTSON NANCY J||Director||65.07K||Sale|
|2021-08-30||INGRAM ROBERT ALEXANDER||Director||77.38K||Stock Award(Grant)|
|2021-06-29||Baker Brothers Advisors, LLC||12.71M||200.96M||7.11%|
|2021-06-29||Vanguard Group, Inc. (The)||9.30M||147.10M||5.20%|
|2021-06-29||State Street Corporation||6.25M||98.86M||3.50%|
|2021-06-29||Sarissa Capital Management, LP||4.26M||67.37M||2.38%|
|2021-06-29||Healthcor Management LP||3.25M||51.35M||1.82%|
|2021-06-29||Vanguard Total Stock Market Index Fund||5.04M||79.67M||2.82%|
|2021-09-29||iShares Russell 2000 ETF||4.05M||58.27M||2.27%|
|2021-09-29||SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF||3.59M||51.62M||2.01%|
|2021-06-29||Vanguard Extended Market Index Fund||2.55M||40.27M||1.42%|
|2021-06-29||Artisan International Small-Mid Fund||2.14M||33.81M||1.20%|
|2021-09-29||iShares Russell 2000 Value ETF||1.73M||24.87M||0.97%|